Cancer Antigen Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

Coverage: Cancer Antigen Market covers analysis ByProduct (Cancer Antigen 125, Cancer Antigen 15-3, Cancer Antigen 27-29, Cancer Antigen 19-9, Others) ; End User (Hospitals, Diagnostic Centres, Ambulatory Surgical Centres, Others), and Geography (North America, Europe, Asia Pacific, and South and Central America)

Publication Month : Apr 2024

  • Report Code : TIPRE00008659
  • Category : Biotechnology
  • Status : Upcoming
  • No. of Pages : 150
Inquire Before Buy

PRICING

$5190

$4671

MARKET OVERVIEW

Cancer antigens are used in identification of the class of monoclonal antibodies. These kits are used for better characterization of antibodies. Cancer antigens are categorized under the immunoassay kits. Cancer antigens help to detect and diagnose various infectious diseases such as dengue, HIV, influenza, Ebola and hepatitis. In addition it also provides information associated to immune response after infection, vaccination and drug therapy.

MARKET SCOPE

The "Global Cancer Antigens Market Analysis to 2028" is a specialized and in-depth study of the biotechnology industry with a special focus on the global market trend analysis. The report aims to provide an overview of the cancer antigens market with detailed market segmentation by product, end user, and geography. The report provides key statistics on the market status of the leading antibody isotyping kit market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

  •  On the basis of product, the market is segmented into Cancer Antigen 125, Cancer Antigen 15-3, Cancer Antigen 27-29, Cancer Antigen 19-9, and others.
  •  Based on end user, the antibody isotyping kit market is classified as hospitals, diagnostic centres, ambulatory surgical centres, others.

MARKET DYNAMICS
Drivers:

  •   Increasing Prevalence Of Cancer
  •   Growing Efforts To Develop Cancer Immunotherapies

Restraints:

  •   Limitation Of Cancer Antigens For The Detection Of Only Specific Types Of Cancer

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The surgical smoke aspirators market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the surgical smoke aspirators market in these regions.

IMPACT OF COVID-19 ON CANCER ANTIGENS MARKET

The cancer antigens market is impacted due to the pandemic. Higher focus on treating soaring number of COVID-19 cases create challenges for the cancer antigens market. Nonetheless, with government and international organizations dedicating their efforts towards containing the pandemic, growth trajectory of the market is expected to improve in the near future..

World Geography

Have a question?

Analyst

Akshay

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Analyst   Speak to Analyst
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities
MARKET PLAYERS


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The surgical smoke aspirators market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the surgical smoke aspirators market in these regions.

IMPACT OF COVID-19 ON CANCER ANTIGENS MARKET

The cancer antigens market is impacted due to the pandemic. Higher focus on treating soaring number of COVID-19 cases create challenges for the cancer antigens market. Nonetheless, with government and international organizations dedicating their efforts towards containing the pandemic, growth trajectory of the market is expected to improve in the near future..

MARKET PLAYERS

The report covers key developments in the cancer antigens market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from cancer antigens market are anticipated to lucrative growth opportunities in the future with the rising demand for cancer antigens in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the cancer antigens market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

  •  THERMO FISHER SCIENTIFIC INC.
  •  F. HOFFMANN-LA ROCHE AG
  •  TELLGEN CORP
  •  LABOR DIAGNOSTIKA NORD GMBH AND COKG
  •  HENSO MEDICAL (HANGZHOU) CO. LTD.
  •  GRITSTONE ONCOLOGY
  •  LEE BIOSOLUTIONS
  •  SHINJIN MEDICS
  •  XIAMEN BAYSEN MEDICA TECH
  •  HANGZHOU ALLTEST BIOTECH

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Cancer Antigen Market - By Product
1.3.2 Cancer Antigen Market - By End User
1.3.3 Cancer Antigen Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. CANCER ANTIGEN MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. CANCER ANTIGEN MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. CANCER ANTIGEN MARKET - GLOBAL MARKET ANALYSIS
6.1. CANCER ANTIGEN - GLOBAL MARKET OVERVIEW
6.2. CANCER ANTIGEN - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING
7. CANCER ANTIGEN MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. CANCER ANTIGEN 125
7.3.1. Overview
7.3.2. Cancer Antigen 125 Market Forecast and Analysis
7.4. CANCER ANTIGEN 15-3
7.4.1. Overview
7.4.2. Cancer Antigen 15-3 Market Forecast and Analysis
7.5. CANCER ANTIGEN 27-29
7.5.1. Overview
7.5.2. Cancer Antigen 27-29 Market Forecast and Analysis
7.6. CANCER ANTIGEN 19-9
7.6.1. Overview
7.6.2. Cancer Antigen 19-9 Market Forecast and Analysis
7.7. OTHERS
7.7.1. Overview
7.7.2. Others Market Forecast and Analysis
8. CANCER ANTIGEN MARKET - REVENUE AND FORECASTS TO 2028 - END USER
8.1. OVERVIEW
8.2. END USER MARKET FORECASTS AND ANALYSIS
8.3. HOSPITALS
8.3.1. Overview
8.3.2. Hospitals Market Forecast and Analysis
8.4. DIAGNOSTIC CENTRES
8.4.1. Overview
8.4.2. Diagnostic Centres Market Forecast and Analysis
8.5. AMBULATORY SURGICAL CENTRES
8.5.1. Overview
8.5.2. Ambulatory Surgical Centres Market Forecast and Analysis
8.6. OTHERS
8.6.1. Overview
8.6.2. Others Market Forecast and Analysis
9. CANCER ANTIGEN MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Cancer Antigen Market Overview
9.1.2 North America Cancer Antigen Market Forecasts and Analysis
9.1.3 North America Cancer Antigen Market Forecasts and Analysis - By Product
9.1.4 North America Cancer Antigen Market Forecasts and Analysis - By End User
9.1.5 North America Cancer Antigen Market Forecasts and Analysis - By Countries
9.1.5.1 United States Cancer Antigen Market
9.1.5.1.1 United States Cancer Antigen Market by Product
9.1.5.1.2 United States Cancer Antigen Market by End User
9.1.5.2 Canada Cancer Antigen Market
9.1.5.2.1 Canada Cancer Antigen Market by Product
9.1.5.2.2 Canada Cancer Antigen Market by End User
9.1.5.3 Mexico Cancer Antigen Market
9.1.5.3.1 Mexico Cancer Antigen Market by Product
9.1.5.3.2 Mexico Cancer Antigen Market by End User
9.1.5.4 US Cancer Antigen Market
9.1.5.4.1 US Cancer Antigen Market by Product
9.1.5.4.2 US Cancer Antigen Market by End User
9.2. EUROPE
9.2.1 Europe Cancer Antigen Market Overview
9.2.2 Europe Cancer Antigen Market Forecasts and Analysis
9.2.3 Europe Cancer Antigen Market Forecasts and Analysis - By Product
9.2.4 Europe Cancer Antigen Market Forecasts and Analysis - By End User
9.2.5 Europe Cancer Antigen Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Cancer Antigen Market
9.2.5.1.1 Germany Cancer Antigen Market by Product
9.2.5.1.2 Germany Cancer Antigen Market by End User
9.2.5.2 France Cancer Antigen Market
9.2.5.2.1 France Cancer Antigen Market by Product
9.2.5.2.2 France Cancer Antigen Market by End User
9.2.5.3 Italy Cancer Antigen Market
9.2.5.3.1 Italy Cancer Antigen Market by Product
9.2.5.3.2 Italy Cancer Antigen Market by End User
9.2.5.4 Spain Cancer Antigen Market
9.2.5.4.1 Spain Cancer Antigen Market by Product
9.2.5.4.2 Spain Cancer Antigen Market by End User
9.2.5.5 United Kingdom Cancer Antigen Market
9.2.5.5.1 United Kingdom Cancer Antigen Market by Product
9.2.5.5.2 United Kingdom Cancer Antigen Market by End User
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Cancer Antigen Market Overview
9.3.2 Asia-Pacific Cancer Antigen Market Forecasts and Analysis
9.3.3 Asia-Pacific Cancer Antigen Market Forecasts and Analysis - By Product
9.3.4 Asia-Pacific Cancer Antigen Market Forecasts and Analysis - By End User
9.3.5 Asia-Pacific Cancer Antigen Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Cancer Antigen Market
9.3.5.1.1 Australia Cancer Antigen Market by Product
9.3.5.1.2 Australia Cancer Antigen Market by End User
9.3.5.2 China Cancer Antigen Market
9.3.5.2.1 China Cancer Antigen Market by Product
9.3.5.2.2 China Cancer Antigen Market by End User
9.3.5.3 India Cancer Antigen Market
9.3.5.3.1 India Cancer Antigen Market by Product
9.3.5.3.2 India Cancer Antigen Market by End User
9.3.5.4 Japan Cancer Antigen Market
9.3.5.4.1 Japan Cancer Antigen Market by Product
9.3.5.4.2 Japan Cancer Antigen Market by End User
9.3.5.5 South Korea Cancer Antigen Market
9.3.5.5.1 South Korea Cancer Antigen Market by Product
9.3.5.5.2 South Korea Cancer Antigen Market by End User
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Cancer Antigen Market Overview
9.4.2 Middle East and Africa Cancer Antigen Market Forecasts and Analysis
9.4.3 Middle East and Africa Cancer Antigen Market Forecasts and Analysis - By Product
9.4.4 Middle East and Africa Cancer Antigen Market Forecasts and Analysis - By End User
9.4.5 Middle East and Africa Cancer Antigen Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Cancer Antigen Market
9.4.5.1.1 South Africa Cancer Antigen Market by Product
9.4.5.1.2 South Africa Cancer Antigen Market by End User
9.4.5.2 Saudi Arabia Cancer Antigen Market
9.4.5.2.1 Saudi Arabia Cancer Antigen Market by Product
9.4.5.2.2 Saudi Arabia Cancer Antigen Market by End User
9.4.5.3 U.A.E Cancer Antigen Market
9.4.5.3.1 U.A.E Cancer Antigen Market by Product
9.4.5.3.2 U.A.E Cancer Antigen Market by End User
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Cancer Antigen Market Overview
9.5.2 South and Central America Cancer Antigen Market Forecasts and Analysis
9.5.3 South and Central America Cancer Antigen Market Forecasts and Analysis - By Product
9.5.4 South and Central America Cancer Antigen Market Forecasts and Analysis - By End User
9.5.5 South and Central America Cancer Antigen Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Cancer Antigen Market
9.5.5.1.1 Brazil Cancer Antigen Market by Product
9.5.5.1.2 Brazil Cancer Antigen Market by End User
9.5.5.2 Argentina Cancer Antigen Market
9.5.5.2.1 Argentina Cancer Antigen Market by Product
9.5.5.2.2 Argentina Cancer Antigen Market by End User
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL CANCER ANTIGEN MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Middle East and Africa
10.5 South and Central America
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOINT VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. CANCER ANTIGEN MARKET, KEY COMPANY PROFILES
12.1. THERMO FISHER SCIENTIFIC INC.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. F. HOFFMANN-LA ROCHE AG
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. TELLGEN CORP
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. LABOR DIAGNOSTIKA NORD GMBH AND COKG
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. HENSO MEDICAL (HANGZHOU) CO.,LTD.
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. GRITSTONE ONCOLOGY
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. LEE BIOSOLUTIONS
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. SHINJIN MEDICS
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. XIAMEN BAYSEN MEDICA TECH
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. HANGZHOU ALLTEST BIOTECH
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. THERMO FISHER SCIENTIFIC INC.
2. F. HOFFMANN-LA ROCHE AG
3. TELLGEN CORP
4. LABOR DIAGNOSTIKA NORD GMBH AND COKG
5. HENSO MEDICAL (HANGZHOU) CO. LTD.
6. GRITSTONE ONCOLOGY
7. LEE BIOSOLUTIONS
8. SHINJIN MEDICS
9. XIAMEN BAYSEN MEDICA TECH
10. HANGZHOU ALLTEST BIOTECH

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Cancer Antigen Market